Abrocitinib: A Comprehensive Review of its Efficacy and Safety in Dermatology
Abrocitinib is a novel oral small molecule which acts as a selective JAK-1 inhibitor. Currently approved for use in moderate-to-severe cases of atopic dermatitis, this drug is gaining a rapid impetus for its use across various inflammatory dermatoses for its selective downstream action on cytokines...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_bfcd9a4c5f2e4b3a93c88432724c5ace | ||
042 | |a dc | ||
100 | 1 | 0 | |a Sunil Dogra |e author |
700 | 1 | 0 | |a Shikha Shah |e author |
700 | 1 | 0 | |a Manavi Gupta |e author |
700 | 1 | 0 | |a Ayush Sharma |e author |
700 | 1 | 0 | |a Seema Chhabra |e author |
245 | 0 | 0 | |a Abrocitinib: A Comprehensive Review of its Efficacy and Safety in Dermatology |
260 | |b Wolters Kluwer Medknow Publications, |c 2024-10-01T00:00:00Z. | ||
500 | |a 2229-5178 | ||
500 | |a 2249-5673 | ||
500 | |a 10.4103/idoj.idoj_449_24 | ||
520 | |a Abrocitinib is a novel oral small molecule which acts as a selective JAK-1 inhibitor. Currently approved for use in moderate-to-severe cases of atopic dermatitis, this drug is gaining a rapid impetus for its use across various inflammatory dermatoses for its selective downstream action on cytokines of the JAK-1 pathway. Its efficacy and safety in atopic dermatitis has been established in phase 3 clinical trials. The future implication of this drug will depend largely on feasibility and practical use in Indian scenario. | ||
546 | |a EN | ||
690 | |a abrocitinib | ||
690 | |a janus kinase | ||
690 | |a jak-stat inhibitor | ||
690 | |a oral small molecule | ||
690 | |a Dermatology | ||
690 | |a RL1-803 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Indian Dermatology Online Journal, Vol 15, Iss 6, Pp 930-941 (2024) | |
787 | 0 | |n https://journals.lww.com/10.4103/idoj.idoj_449_24 | |
787 | 0 | |n https://doaj.org/toc/2229-5178 | |
787 | 0 | |n https://doaj.org/toc/2249-5673 | |
856 | 4 | 1 | |u https://doaj.org/article/bfcd9a4c5f2e4b3a93c88432724c5ace |z Connect to this object online. |